Showing 7 of 7 recruiting trials for “Immunoglobulin A nephropathy”
Study of BHV-1400 in IgA Nephropathy
Study of Ravulizumab in Pediatric Participants With Primary IgAN
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
Phase 2/3 Open-Label Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy
🏥 Otsuka Pharmaceutical Development & Commercialization, Inc.📍 1 site📅 Started Apr 2022View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →